“Latest Stem Cells News”

Scientists in the U.S. have made history as they have found a brand new, safer way to create embryonic stem cells.
Washington (dbTechno) – Scientists in the U.S. have made history as they have found a brand new, safer way to create embryonic stem cells.
There has been a great debate over the years due to safety concerns in regards to the development of embryonic stem cells, seen by many as the future of medicine.

This debate may now be put to rest though thanks to this new research announced this week.

Incoming search terms:

Stem Cell Research Brings About Another Miracle

Korean doctors have apparently regrown a patient’s jawbone using the patient’s own Adult Stem Cells in yet another amazing miracle that Adult Stem Cell research has brought us.

An 18 year old Korean boy who had to have most of his jawbone and his teeth removed due to a tumor was the lucky recipient of this fantastic stem cell research victory.

The young man, who had been suffering confidence problems due to his appearance (missing his jawbone and teeth) is very happy now after the Adult Stem Cells worked their magic and regrew his jawbone so he looks normal in appearance now.

Process of Stem Cells

1. Adult Stem Cells were taken from the man’s bone marrow
2. They were then multiplied and “coached” into becoming an osteoblast- a cell responsible for bone formation
3. The new Adult Stem Cells were injected into the “damaged” area around the man’s jaw
4. 6 months-1 year the stem cells grow new bone to fill in the gap left when the jawbone and teeth were removed
5. Man’s looks better, has more confidence, happier

Stem Cell Case Study Presented at Conference

The results of the trial were published in the British medical journal BMC Medicine and it was also presented at the Korean Association of Oral and Maxillofacial Surgeons annual meeting (Those silly Maxillofacial surgeons must have forgotten my invitation)

Another Case of Adult Stem Cell Research Working Magic

This is just another instance in which the patient’s own stem cells were used to help. The patient had nothing to lose (no side effects because they were his own stem cells), and everything to gain. And gain he did with this miracle.

This reminds me of an amazing story in Germany a few years back in which they actually used a man’s back as an incubator and grew him a new jawbone

Click here to read the whole stem cell article

from Don Margolis

Incoming search terms:

DURHAM — To donate the stem cell-rich umbilical cord blood produced during the birth of her daughter, Jaime Feaster of Lake Charles, La., would have had to drive more than two hours to the nearest hospital equipped to collect it.

That’s a long way to go when you’re in labor.

Instead, Feaster turned to a fledgling Duke University Medical Center program that provides collection kits to mothers and their doctors. When Feaster’s daughter, Kadee, arrived last month, the cord blood was collected, packaged and quickly shipped to a blood bank at no cost to Feaster and with minimal commitment of time and expertise from her doctor.

Duke doctor Joanne Kurtzberg wants to replicate Feaster’s experience on a large scale.

Kurtzberg hopes that an easier donation process will trigger a surge in donations of blood cells so valuable they’ve been used to reverse and even cure otherwise fatal disorders. The current cord blood supply can’t keep up with the demand for its use in treating leukemia, sickle cell disease and other blood disorders, and the nation’s hospital infrastructure isn’t set up to tap even a fraction of the potential donors.

Incoming search terms:

“For centuries, scientists have known that certain animals can regenerate missing parts of their bodies. Humans actually share this ability with animals like the starfish and the newt. Although we can’t replace a missing leg or a finger, our bodies are constantly regenerating blood, skin, and other tissues.

The identity of the powerful cells that allow us to regenerate some tissues was first revealed when experiments with bone marrow in the 1950s established the existence of stem cells in our bodies and led to the development of bone marrow transplantation, a therapy now widely used in medicine.

This discovery raised hope in the medical potential of regeneration. For the first time in history, it became possible for physicians to regenerate a damaged tissue with a new supply of healthy cells by drawing on the unique ability of stem cells to create many of the body’s specialized cell types (…)”

Read full story clicking here

Incoming search terms:

BioMedReports: There has been some talk about the upcoming opening of your new state-of-the-art facility. Can you tell us about that?

CEO Matthew L. Schissler: We always try to focus on three core goals and in 2010 we are opening our new state of the art laboratory. One of those three core goals is the diversification of revenue streams. Not only will we have our own organic growth engine, by processing and storing for our own company, but we recently entered into a letter of agreement to process and store for another very successful stem cell company. That’s going to be the flavor for 2010 and onward- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth- like we saw mention of when we announced in late 2009 when we signed an agreement with a national labor association, Blue Cross and Blue Shield Association. That’s how we’ll grow some more, through the insurance companies. And finally, we’re going to be very focused on acquisitions. In fact, I’ll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we’ve been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it’s a very good time for us to make some acquisitions and so we’re going to be very focused on that this year.

BioMedReports: So I would imagine that these acquisitions are somehow related to the goal of increasing your revenue streams in some way?

CEO Matthew L. Schissler: The overall goal in our mission statement is to not only become the world’s number one most respected stem cell company but also to be the largest as well. As we say in our mission statement, the world’s globally dominant stem cell storage company and so, those acquisitions will be in related fields, but I can’t say too much but it’s all about cryogenic preservation of stem cells and other forms of biologics.

Researchers and using stem cells as tools for disease study, drug screening, clinical trial strategy, and personalized medicine. The induced Pluripotent Stem cell (iPS) is giving us a chance to rethink the way we are developing new drugs. These iPS cells are usually created from somatic cells (such as skin), and not embryos or adult stem cells. In creating iPS from patients’ diseased cells, scientists can study the disease in vitro, looking for disease phenotypes, applying microenvironmental stress, and testing new drugs. Compared to animal model testing (e.g. mice), this represents a significant breakthrough, that can be used to validate clinical development strategy and test efficacy in specific groups of patients. iPS is bringing a revolution in drug discovery methodology which is being used to bridge genetics, cell biology, and physiology.

from http://biobusiness.tv/videos/208

Incoming search terms: